首页> 外国专利> VACCINE AGAINST associated virus diarrhea, rotavirus and coronavirus infections in cattle emulsion INACTIVATED

VACCINE AGAINST associated virus diarrhea, rotavirus and coronavirus infections in cattle emulsion INACTIVATED

机译:牛乳中疫苗针对相关的病毒性腹泻,轮状病毒和冠状病毒感染

摘要

1. A vaccine against a viral-associated diarrhea (VD), rotavirus and coronavirus infections of cattle (RNC) inactivated emulsion containing the active substance and the desired additives, characterized in that as an active substance it contains a mixture of purified antigenic material avirulent strain " NADL-ARRIAH "virus WA cattle, herewith. Flaviviridae, genus Pestivirus, collection FSI "VGNKI» «NADL-ARRIAH" -DEP from avirulent antigenic material purified from strain «№101 ARRIAH" rotavirus RNC, Sem. Reoviridae, genus Rotavirus, collection VGNKI «№101 ARRIAH-DEP" and purified from the avirulent antigenic material from strain "ARRIAH" RNC coronavirus, Sem. Coronaviridae, kind Coronaivirus, collection VGNKI "ARRIAH-DEP" in an effective kolichestve.2. Vaccine according to claim 1, characterized in that it contains an avirulent and purified antigenic material from strain «NADL-ARRIAH" VD RNC virus obtained in continuous culture of mammalian cells in an effective kolichestve.3. Vaccine according to claim 2, characterized in that it contains an avirulent and purified antigenic material from strain «NADL-ARRIAH" VD RNC virus obtained in continuous culture of bovine kidney cells (Taurus-2) in the effective kolichestve.4. A vaccine according to claim 3, characterized in that it contains an avirulent and purified antigenic material from strain «NADL-ARRIAH" RNC virus obtained in the continuous culture of cells Taurus-2 infectivity least 6,0 lg TCD / cc activity in ELISA not less than 6.65 1ogdo inactivation in an amount of 10.0 wt.%. 5. Vaccine according to claim 2, characterized in that it contains an avirulent and purified antigenic material from strain «NADL-ARRIAH" virus VD RNC resultant ne
机译:1.一种针对牛的病毒相关性腹泻(VD),轮状病毒和冠状病毒感染(RNC)灭活的乳状液的疫苗,其包含活性物质和所需的添加剂,其特征在于作为活性物质,其包含无毒的纯化抗原物质的混合物病毒“牛”的“ NADL-ARRIAH”毒株。黄病毒科,瘟病毒属,从从“№101ARRIAH”株轮状病毒RNC,Sem。呼肠病毒科,轮状病毒属中纯化的无毒抗原物质中收集FSI“ VGNKI»«NADL-ARRIAH” -DEP,并纯化,并纯化来自菌株“ ARRIAH” RNC冠状病毒,Sem的无毒抗原物质。冠状病毒科病毒,冠状病毒,有效的收集了VGNKI“ ARRIAH-DEP”。 2.根据权利要求1所述的疫苗,其特征在于,其包含来自哺乳动物细胞在有效的鞘管中连续培养获得的«NADL-ARRIAH” VD RNC毒株的无毒和纯化的抗原物质。3.根据权利要求2所述的疫苗,其特征在于,它包含来自“ NADL-ARRIAH” VD RNC病毒的无毒和纯化抗原材料,该病毒是在有效的kolichestve中连续培养牛肾细胞(Taurus-2)获得的。4。 4.根据权利要求3所述的疫苗,其特征在于,所述疫苗包含来自菌株“ NADL-ARRIAH” RNC病毒的无毒的和纯化的抗原物质,所述菌株是在连续培养的细胞Taurus-2中获得的,感染性至少为6.0 lg TCD / cc,在ELISA中没有。 5,根据权利要求2的疫苗,其特征在于,其小于6.65 1ogdo灭活的量为10.0重量%5,根据权利要求2所述的疫苗,其特征在于,所述疫苗包含来自菌株“ NADL-ARRIAH”病毒VD RNC的无毒和纯化的抗原材料。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号